# A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

> **NCT02594033** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 46 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT02594033
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-27
- **Primary completion:** 2016-01-28
- **Final completion:** 2016-01-28
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594033, "A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02594033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*